Home
DIVISLAB.NS

Divi's Laboratories Limited

NSEHealthcare
₹6,758.00
+1.13%+₹75.50 today
₹0.00₹0.00
Ask Warren
Open
₹0.00
Prev close
₹6,682.50
Day range
₹0 – ₹0
52W range
₹5,636.5 – ₹7,071.5
Volume
3.8L
Avg vol (20D)
3.5L
Mkt cap
₹1,79,377.12Cr
P/E TTM
69.7×

Trade Divi's Laboratories Limited with Artha

Sign in to place orders, set alerts, and sync your watchlist.

Sign in to trade

Company Metrics

Revenue (ttm)₹10560.00 Cr
Net Income (ttm)₹0.00
Shares Out26.55 Cr
EPS (ttm)
Forward PE
Dividend
Ex-Dividend DateInvalid Date

Trading Metrics

Beta0.22

About DIVISLAB.NS

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees0
Stock ExchangeNSE
Ticker SymbolDIVISLAB.NS
DIVISLAB.NS · NSE
Financial Performance

In 2026, Divi's Laboratories Limited's revenue was ₹10560.00 Cr, an increase of +9.50% compared to the previous year. Earnings were ₹0.00, an increase of +13.60%.

Revenue (2026)
₹10560.00 Cr
+9.50% YoY
Earnings (2026)
₹0.00
+13.60% YoY
Year-over-Year Growth
Revenue
+9.50%
Earnings
+13.60%

News

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades
Create free account

We use analytics cookies to understand how you use Artha and improve your experience. No data is sold to third parties.